Skip to main content

Table 2 The clinical characteristics of health management cohort from Tangshan

From: Large-scale in silico identification of drugs exerting sex-specific effects in the heart

 

Men

Women

P values

N

86

67

 

Age

55.23 ± 10.56

59.55 ± 7.65

0.0039

SBP (mmHg)

149.2 ± 16.45

153.3 ± 20.84

0.1809

DBP (mmHg)

96.63 ± 11.44

89.27 ± 13.43

0.0004

HR (bmp)

72.66 ± 11.61

72.48 ± 14.07

0.9362

BMI (kg/m2)

26.78 ± 2.99

26.42 ± 3.52

0.4875

Glu (mM)

6.21 ± 2.04

6.11 ± 2.02

0.7596

TG (mM)

1.93 ± 1.29

2.29 ± 1.72

0.1581

TC (mM)

4.74 ± 1.01

5.17 ± 0.87

0.0067

HDL-c (mM)

1.08 ± 0.18

1.21 ± 0.28

0.0015

LDL-c (mM)

2.74 ± 0.65

2.93 ± 0.60

0.0599

Other medication

ACEI (1)

ACEI (4)

 

ARB (3)

ARB (1)

 

CCB (11)

CCB (5)

 

Diuretics (3)

Diuretics (1)

 

Co-morbidities

Diabetes (29)

Diabetes (15)

 

Stroke (6)

CHD (3)

 
  1. SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, BMI body mass index, Glu fasting serum glucose, TG serum triglyceride, TC serum total cholesterol, HDL high density lipoprotein cholesterol, LDL-c low density lipoprotein cholesterol, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, CCB calcium channel blockers, CHD coronary heart disease